Structure Image | Chemical Name | CAS Number | Molecular Formula |
---|---|---|---|
|
3-Cyano-2,6-dimethyl-4-(4-thiomorpholinyl)pyridine N-oxide hydrochloride | 106101-15-9; 106101-47-7 (free base) | C12H15N3OS.ClH |
|
24-(9H-Pyrido[3,4-b]indol-1-yl)-2,3,5,6,7,8,11,12,13,13a,15,16,17,18,20a,21-hexadecahydro-1,13-etheno-4,21a-methano-1H-azocino[1′,2′:1,5]pyrrolo[3,2-e]azacyclopentadecin-13-ol | C36H44N4O | |
|
2(S)-(6-Methoxynaphthalen-2-yl)propionic acid 2-(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl)ethyl ester | C29H34O5 | |
|
1-(2,4-Dichlorophenyl)-1-[4-[N-methyl-N-(1-naphthylmethyl)aminomethyl]phenyl]methanone | C26H21Cl2NO | |
|
N-[4-Guanidino-1(S)-[4-(2-hydroxyethyl)piperidin-1-ylcarbonyl]butyl]-3,3-dimethyl-1,2,3,4-tetrahydroquinoline-8-sulfonamide | 184037-69-2; 184037-70-5 (acetate) | C24H40N6O4S |
|
(2R,6S)-3-[2(S)-Benzyloxypropyl]-6,11,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol hydrochloride | 221018-88-8; 221019-25-6 (free base) | C25H33NO2.ClH |
|
3-Benzyl-1-(3-guanidinobenzyl)-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one | C30H27N5O | |
|
15-Deoxy-20-ethyl-15-oxo-13,14-dihydroprostaglandin F2alpha isopropyl ester; 20-Ethyl-9alpha,11alpha-dihydroxy-15-oxoprost-5(Z)-enoic acid isopropyl ester; [1R-[1alpha(Z),2beta,3alpha,5alpha]]-7-[3,5-Dihydroxy-2-(3-oxodecyl)cyclopentyl]-5-heptenoic acid | 120373-24-2 | C25H44O5 |
|
4-Amino-5-chloro-2-methoxy-N-[1-[2-(methylsulfonamido)ethyl]piperidin-4-ylmethyl]benzamide oxalate | C17H27ClN4O4S.C2H2O4 | |
|
5-[4-[2-[1-(Biphenyl-4-yl)ethylideneaminooxy]ethoxy]benzyl]thiazolidine-2,4-dione | C26H24N2O4S |